Patent · US Active

Compositions and methods for treating intestinal hyperpermeability

US10517845B2 · kind B2 · utility

4Cited by
15References
14Claims
0Family size

Inventor

Key dates

Filing dateAug 27, 2018
Grant dateDec 31, 2019
Priority date—
Expiry dateAug 27, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K45/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods, compositions, and kits for treating intestinal hyperpermeability in a subject in need thereof, including conditions such as hyperglycemia and underlying diseases such as diabetes, autism, fibromyalgia, inflammatory bowel disease (IBD), graft versus host disease (GVHD), HIV/AIDS, multiple organ dysfunction syndrome, irritable bowel syndrome (IBS), celiac disease, eczema, psoriasis, acute pancreatitis, Parkinson's disease, depression, chronic fatigue syndrome, asthma, multiple sclerosis, arthritis, ankylosing spondylitis, nonalcoholic fatty liver disease, alcoholic cirrhosis, environmental enteropathy, or kwashiorkor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.